Wyeth files pneumococcal vaccine Prevenar-13 in EU
This article was originally published in Scrip
Executive Summary
Wyethhas filed its investigational 13-valent pneumococcal vaccine, Prevenar-13 (PCV13), with the EMEA for the prevention of pneumococcal disease in infants and young children.